First, we determined the cytotoxic effect of the HDAC inhibitor MPT0E028 or SAHA plus the selective MEK/ERK kinase inhibitor PD98059 or trametinib in three different pancreatic cancer cell lines. The gene discussed is MAP2K7; the disease is pancreatic neoplasm.